Modern Meadow racks up $40 mln Series B
New York City-based Modern Meadow, a biofabrication company that grows animal-free leather made from living cells, has secured $40 million in Series B financing. Horizons Ventures and Iconiq Capital led the round with participation from other investors that included ARTIS Ventures, Temasek, Breakout Ventures, Red Swan Ventures, Collaborative Fund and Tony Fadell.
28 June 2016•1 min read
